Zhang Y J, Jiang W, Chen C J, Lee C S, Kahn S M, Santella R M, Weinstein I B
Comprehensive Cancer Center, School of Public Health, Columbia University, New York, NY 10032.
Biochem Biophys Res Commun. 1993 Oct 29;196(2):1010-6. doi: 10.1006/bbrc.1993.2350.
Amplification of the chromosome 11q13 region occurs in several types of human cancer including esophageal, breast, lung, bladder and hepatocellular carcinoma (HCC). The gene cyclin D1 maps to this region in close proximity to two proto-oncogenes hst-1 and int-2. We previously demonstrated that cyclin D1 was not only amplified but also overexpressed in about 30% of human esophageal cancers. To investigate the role of cyclin D1 in human hepatocellular carcinoma (HCC), DNA from 30 HCC and 5 control liver tissues from Taiwan and also the HCC cells lines HepG2 and Hep3B, were examined for amplification of the cyclin D1 gene. A 3 to 20-fold amplification was found in 4 of the 30 (13%) HCC samples but not in any of the 5 control tissues or the 2 cell lines. Immunohistochemical analysis of cyclin D1 indicated overexpression of this protein in tumors that displayed gene amplification. Weak or negative staining was observed in the other HCC samples as well as in the control tissues and cell lines. These data suggest that increased expression of cyclin D1 may play an important role in the development of a subset of human HCC, perhaps by perturbing normal control of the cell cycle.
11号染色体q13区域的扩增发生在多种人类癌症中,包括食管癌、乳腺癌、肺癌、膀胱癌和肝细胞癌(HCC)。细胞周期蛋白D1基因定位于该区域,紧邻两个原癌基因hst-1和int-2。我们先前证明,细胞周期蛋白D1不仅在约30%的人类食管癌中发生扩增,而且过度表达。为了研究细胞周期蛋白D1在人类肝细胞癌(HCC)中的作用,检测了来自台湾的30例HCC和5例对照肝组织的DNA,以及HCC细胞系HepG2和Hep3B的细胞周期蛋白D1基因扩增情况。在30例(13%)HCC样本中的4例中发现了3至20倍的扩增,但在5例对照组织或2个细胞系中均未发现。细胞周期蛋白D1的免疫组织化学分析表明,在显示基因扩增的肿瘤中该蛋白过度表达。在其他HCC样本以及对照组织和细胞系中观察到弱阳性或阴性染色。这些数据表明,细胞周期蛋白D1表达增加可能在一部分人类HCC的发生发展中起重要作用,可能是通过扰乱细胞周期的正常调控。